Polyrizon partners with Clearmind to develop intranasal MEAI formulation

Go back to Polyrizon partners with Clearmind to develop intranasal MEAI formulation
(NASDAQ: CMND) Delayed: 5.97 -0.15 (2.45%)
Previous Close $6.12    52 Week High $ 
Open $6.10    52 Week Low $ 
Day High $6.10    P/E N/A 
Day Low $5.95    EPS $ 
Volume 5,464       

(NASDAQ: PLRZ) Delayed: 8.58 -0.38 (4.24%)
Previous Close $8.96    52 Week High $ 
Open $8.74    52 Week Low $ 
Day High $8.97    P/E N/A 
Day Low $8.54    EPS $ 
Volume 5,287